US EditionCND Life Sciences Closes $13.5M Series A Funding
Summary by FinSMEs
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
CND Life Sciences Closes $13.5M Series A Funding
CND Life Sciences, a Scottsdale, AZ-based neurodiagnostics startup, raised $13.5m in Series A equity financing round, with $8.6m in its most recent Series A3 offering. Series A3 backers included Cambrian Capital Partners, Tanis Ventures, Lupo Labs, Top Corner Capital, HonorHealth, Triana, Gold Bench Capital, BlueStone Ventures, Labcorp, MBX Capital and Vilas Ventures. Led by Richard J. Morello, chief executive officer, […] The post CND Life Sci…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
